Charged-balanced imaging agents

US9687567B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9687567-B2
Application numberUS-201514681068-A
CountryUS
Kind codeB2
Filing dateApr 7, 2015
Priority dateFeb 6, 2009
Publication dateJun 27, 2017
Grant dateJun 27, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to compositions for and methods of optically imaging tissues or cells using imaging agents having desirable in vivo properties that result in improved signal-to-background ratio.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of imaging tissue or cells, the method comprising: (a) contacting the tissue or cells with an imaging agent comprising a dye; (b) irradiating the tissue or cells at a wavelength absorbed by the dye; (c) detecting an optical signal from the irradiated tissue or cells, wherein the signal-to-background ratio of the detected optical signal is at least about 1.1, thereby imaging the tissue or cells; wherein the dye has the formula V: wherein: G is independently selected from H, C 1-6 alkyl, a moiety comprising a linking group, and a moiety comprising a targeting ligand; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from H, an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; or two adjacent R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 groups, together with the atoms to which they are attached, form a fused 5-7 membered aryl, heteroaryl, cycloalkyl, or heterocycloalkyl group, each optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 9 , and R 10 , are independently selected from an ionic group, a non-ionic oligomeric or polymeric solubilizing group, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 11 and R 12 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 13 and R 14 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 15 and R 16 are independently selected from H and C 1-6 alkyl; R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 are independently selected from independently an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl; and n is −1, 0 or +1, wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 is an ionic group. 2. A dye, having the formula V: wherein: G is independently selected from H, C 1-6 alkyl, a moiety comprising a linking group, and a moiety comprising a targeting ligand; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from H, an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; or two adjacent R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 groups, together with the atoms to which they are attached, form a fused 5-7 membered aryl, heteroaryl, cycloalkyl, or heterocycloalkyl group, each optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 9 , and R 10 , are independently selected from an ionic group, a non-ionic oligomeric or polymeric solubilizing group, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 11 and R 12 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 13 and R 14 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 15 and R 16 are independently selected from H and C 1-6 alkyl; R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 are independently selected from independently an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl; and n is −1, 0 or +1, wherein the ester is a conjugate of one or more of an ionic group and/or the linking group. 3. An ester conjugate of a dye, having the formula V: wherein: G is independently selected from H, C 1-6 alkyl, a moiety comprising a linking group, and a moiety comprising a targeting ligand; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from H, an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; or two adjacent R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 groups, together with the atoms to which they are attached, form a fused 5-7 membered aryl, heteroaryl, cycloalkyl, or heterocycloalkyl group, each optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 9 , and R 10 , are independently selected from an ionic group, a non-ionic oligomeric or polymeric solubilizing group, C 1-6 alkyl, aryl, and heteroaryl, wherein said alkyl, aryl, and heteroaryl groups are optionally substituted with 1, 2, 3, 4, or 5 groups independently selected from halo, cyano, nitro, and C 1-4 haloalkyl; R 11 and R 12 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 13 and R 14 are independently selected from C 1-4 alkyl optionally substituted with 1, 2, or 3 halo; R 15 and R 16 are independently selected from H and C 1-6 alkyl; R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 are independently selected from independently an ionic group, a non-ionic oligomeric or polymeric solubilizing group, halo, C 1-6 alkyl, aryl, and heteroaryl; and n is −1, 0 or +1, wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 is an ionic group; wherein the ester conjugate permits covalent conjugation of the fluorophore to targeting ligands. 4. The ester conjugate of claim 3 , wherein the ester is an N-hydroxysuccinimide ester.

Assignees

Inventors

Classifications

  • not condensed with other rings · CPC title

  • with fluorescent label · CPC title

  • involving viable microorganisms · CPC title

  • more than five >CH- groups · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9687567B2 cover?
The present invention relates to compositions for and methods of optically imaging tissues or cells using imaging agents having desirable in vivo properties that result in improved signal-to-background ratio.
Who is the assignee on this patent?
Beth Israel Deaconess Medical Ct Inc, Univ Georgia State Res Found Inc, Univ Georgia State Res Found Inc
What technology area does this patent fall under?
Primary CPC classification A61K49/0032. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).